Mergers & Acquisitions News 30 October 2025

Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Stock Price and Recent Performance Year-to-date chart of Evoke Pharma (EVOK) stock through early November 2025. Shares were volatile throughout 2025, and the Q4 acquisition announcement (right end of chart) triggered a dramatic spike to new highs, bringing the stock

4 November 2025

Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Stock Price & Recent Performance Denny’s stock was under pressure for most of 2025 before the buyout news. The share price started the year in the mid-single digits and drifted lower amid uninspiring financial results and sector-wide challenges. In fact,

4 November 2025

Business News · Earnings Reports · Investment Analysis · Mergers & Acquisitions · Stock Market

Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue (KVUE) Stock Soars 20% on $48.7 B Buyout News – Q3 Earnings Beat and What’s Next

Stock Price and Intraday Performance (Nov 3, 2025) Kenvue’s stock soared on the buyout news, delivering a sharp one-day gain. As of midday Nov. 3, KVUE traded around $17–$18, up roughly 18–20% intraday reuters.com. Prior to the announcement, the stock

3 November 2025

Earnings Reports · Financial News · Investing · Mergers & Acquisitions · NYSE:KMB · NYSE:KVUE · Stock Market

Merger Showdown: Union Slams Crédit Agricole–Banco BPM Deal Over Job Cuts and “Deserted” Towns

Union Sounds Alarm on Bank Merger Italian bank workers’ union First CISL has delivered a stark warning about the rumored merger between Banco BPM and Crédit Agricole Italia. On October 31, the union publicly rejected the potential deal, saying it

3 November 2025

Banking · Economic Impact · Finance News · Labor Relations · Mergers & Acquisitions

Brighthouse Financial (BHF) Stock Soars on Takeover Buzz – Price Jump, Earnings Outlook & Expert Analysis

Short-Term and Long-Term Outlook Deal or No Deal: In the short term, Brighthouse’s fate may hinge on the takeover negotiations. If Aquarian finalizes a buyout near $70/share, the stock could quickly gravitate toward that price (roughly 25% above where it

31 October 2025

Earnings Reports · Financial News · Investing · Mergers & Acquisitions · NYSE:BHF · Stock Market

Chevron (CVX) Stock Rallies on $2B Pipeline Deal – Could $200 Be Next?

Chevron’s Next Big Move: CVX Stock Could Skyrocket on $55B Hess Deal & Low-Carbon Push

In summary, as of Oct 31, 2025 Chevron stands as a dividend-rich, integrated energy leader navigating a weak-oil cycle. Its stock is trading near multi-month lows but backed by record production and cash flow. Short-term catalysts include the Hess synergies and

31 October 2025

Energy · Green Technology · Mergers & Acquisitions · NYSE:CVX · Oil & Gas · Stock Analysis

Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk’s $9B Shock Bid Snatches US Weight-Loss Biotech from Pfizer – Stocks React Big

Bidding War Ignites for Obesity Biotech Novo’s takeover push marks a sudden escalation in the weight-loss drug wars. The Danish company – maker of Wegovy and Ozempic – broke ranks on Oct. 30 by notifying Metsera’s board of its superior

31 October 2025

Biotech Industry · Mergers & Acquisitions · NASDAQ:MTSR · NYSE:NVO · NYSE:PFE · Pharma News · Stock Market · Weight Loss

Activist Investor Shocks Wall Street: $10.9B Comerica Sale Sparks Bank M&A Boom

Activist Investors Target Underperforming Banks Until recently, regional banks drew little activist attention. That changed when HoldCo Asset Management loudly challenged Comerica’s board. In July 2025 HoldCo issued a report warning that Comerica and other midsize banks had underperformed due

31 October 2025

Banking · Finance · Investment · Mergers & Acquisitions · NASDAQ:CADE · NASDAQ:COLB · NASDAQ:EBCI · NASDAQ:FIBK · NYSE:CMA · NYSE:COF · NYSE:DFS · NYSE:FITB · NYSE:HBAN · Stock Market

Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies (RKT) Stock Soars after $14B Mortgage Mega-Merger and Earnings Beat – What’s Next?

Stock Performance and Recent Moves Rocket Companies (NYSE: RKT) has been one of 2025’s surprise gainers in the mortgage sector. Its shares peaked in the low-$20s in early October on merger excitement, but have since pulled back into the mid-$16s

30 October 2025

Financial News · Investing · Mergers & Acquisitions · Mortgage Industry · NASDAQ:COOP · NASDAQ:RDFN · NYSE:RKT · Stock Market

Terex (TEX) Stock Crashes 18% on Surprise REV Group Merger News

In-Depth Analysis Terex’s stock slump on Oct. 30 came amid two shocks: mixed Q3 earnings results and a transformational merger announcement. After a previous close near $56, shares briefly traded in the mid-$40s, reflecting roughly an 18% intraday fall stockanalysis.com

30 October 2025

Company Analysis · Financial News · Investment · Mergers & Acquisitions · NYSE:REVG · NYSE:TEX · Stock Market

Metsera Stock Skyrockets as Pfizer-Novo Clash in $9B Bidding War

Bidding War Sends Metsera Shares Higher Metsera’s share price has been on a roller-coaster amid takeover speculation. In late September, Pfizer agreed to buy Metsera for $47.50 per share in cash (about $4.9B) plus up to $22.50 in contingent payments

30 October 2025

Business · Investing · Mergers & Acquisitions · NASDAQ:MTSR · NYSE:NVO · NYSE:PFE · Pharma News · Stock Market

Novo Nordisk hijacks Pfizer’s Metsera deal with a $9B bid – obesity-drug war heats up

Novo’s counter-offer details Novo Nordisk’s proposal is unsolicited, meaning Metsera’s board and shareholders will now review it against Pfizer’s agreement. Novo emphasizes that Metsera’s experimental therapies would be “complementary” to its own obesity portfolio reuters.com. According to MarketScreener (Dow Jones

30 October 2025

Biotechnology · Industry News · Mergers & Acquisitions · NYSE:NVO · NYSE:PFE · Obesity Drugs · Pharmaceuticals

Mergers & Acquisitions News 30 October 2025 - 4 November 2025